Diagnostic Accuracy of Right Ventricular Dysfunction Markers in Normotensive Emergency Department Patients With Acute Pulmonary Embolism - 25/08/16
, Gregory Thacker, MD, Daniel Troha, MD, Angela K. Johnson, MD, Jordan Chanler-Berat, MD, H. James Norton, PhD, Michael Runyon, MDAbstract |
Study objective |
We determine the diagnostic accuracy of goal-directed echocardiography, cardiac biomarkers, and computed tomography (CT) in early identification of severe right ventricular dysfunction in normotensive emergency department patients with pulmonary embolism compared with comprehensive echocardiography.
Methods |
This was a prospective observational study of consecutive normotensive patients with confirmed pulmonary embolism. Investigators, blinded to clot burden and biomarkers, performed qualitative goal-directed echocardiography for right ventricular dysfunction: right ventricular enlargement (diameter greater than or equal to that of the left ventricle), severe right ventricular systolic dysfunction, and septal bowing. Brain natriuretic peptide and troponin cutoffs of greater than or equal to 90 pg/mL and greater than or equal to 0.07 ng/mL and CT right ventricular:left ventricular diameter ratio greater than or equal to 1.0 were also compared with comprehensive echocardiography.
Results |
One hundred sixteen normotensive pulmonary embolism patients (111 confirmed by CT, 5 by ventilation-perfusion scan) were enrolled. Twenty-six of 116 patients (22%) had right ventricular dysfunction on comprehensive echocardiography. Goal-directed echocardiography had a sensitivity of 100% (95% confidence interval [CI] 87% to 100%), specificity of 99% (95% CI 94% to 100%), positive likelihood ratio (+LR) of 90.0 (95% CI 16.3 to 499.8), and negative likelihood ratio (–LR) of 0 (95% CI 0 to 0.13). Brain natriuretic peptide had a sensitivity of 88% (95% CI 70% to 98%), specificity of 68% (95% CI 57% to 78%), +LR of 2.8 (95% CI 2.0 to 3.9), and –LR of 0.17 (95% CI 0.06 to 0.43). Troponin had a sensitivity of 62% (95% CI 41% to 80%), specificity of 93% (95% CI 86% to 98%), +LR of 9.2 (95% CI 4.1 to 20.9), and –LR of 0.41 (95% CI 0.24 to 0.62). CT had a sensitivity of 91% (95% CI 72% to 99%), specificity of 79% (95% CI 69% to 87%), +LR of 4.3 (95% CI 2.8 to 6.7), and –LR of 0.11 (95% CI 0.03 to 0.34).
Conclusion |
Goal-directed echocardiography was highly accurate for early severe right ventricular dysfunction identification and pulmonary embolism risk-stratification. Brain natriuretic peptide was sensitive but less specific, whereas troponin had lower sensitivity but higher specificity. CT had good sensitivity and moderate specificity.
Le texte complet de cet article est disponible en PDF.Plan
| Please see page 278 for the Editor’s Capsule Summary of this article. |
|
| Supervising editor: William R. Mower, MD, PhD |
|
| Author contributions: AJW and DT conceived the study and designed the trial. AJW supervised the conduct of the trial and data collection. AJW, GT, DT, AKJ, and JC-B enrolled patients. MR provided statistical advice on study design and analyzed the data. AJW and GT managed the data, including quality control, and drafted the article. All authors contributed substantially to article revision. AJW takes responsibility for the paper as a whole. |
|
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org/). The authors have stated that no such relationships exist. |
|
| A JX5CWFX survey is available with each research article published on the Web at www.annemergmed.com. |
|
| A podcast for this article is available at www.annemergmed.com. |
Vol 68 - N° 3
P. 277-291 - septembre 2016 Retour au numéro
Article précédent
- Young Male With Painful Skin Necrosis
- Ze-Hu Liu, Hong Shen
- Interrogation of Patient Smartphone Activity Tracker to Assist Arrhythmia Management
- Joshua Rudner, Carol McDougall, Vivek Sailam, Monika Smith, Alfred Sacchetti
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?